z-logo
Premium
NF‐κB inhibition and ischemic preconditioning ameliorate ischemia‐reperfusion injury in dystrophin‐deficient muscles of mdx mice
Author(s) -
Ye Jianfeng,
Thomas Gail D
Publication year - 2009
Publication title -
the faseb journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.709
H-Index - 277
eISSN - 1530-6860
pISSN - 0892-6638
DOI - 10.1096/fasebj.23.1_supplement.782.9
Subject(s) - dystrophin , duchenne muscular dystrophy , ischemia , pharmacology , reperfusion injury , chemistry , mdx mouse , muscular dystrophy , ischemic preconditioning , medicine , endocrinology
Mutations of the dystrophin gene cause Duchenne muscular dystrophy, but the pathogenetic mechanisms are poorly understood. We previously reported that ischemia and reperfusion (I/R) cause excessive injury to dystrophin‐deficient muscles, which is ameliorated by antioxidant treatment. We therefore hypothesized that the enhanced susceptibility of the dystrophin‐deficient muscles of mdx mice to I/R‐induced injury is mediated by activation of the redox‐sensitive transcription factor NF‐κB. Because brief exposure to ischemia induces tolerance to subsequent I/R and is thought to be mediated in part by reactive oxygen species, we also hypothesized that I/R‐induced injury would be reduced by ischemic preconditioning (IPC). In anesthetized mdx and C57BL10 mice, I/R (1 h/2 h) induced greater sarcolemmal damage as reflected by Evans blue dye (EBD) uptake (EBD + area: 29±3% vs 6±2%; P<0.05) and greater activation of NF‐κB (+115±32% vs +36±16%; P<0.05). I/R‐induced injury in mdx mice was attenuated by pharmacological inhibition of NF‐κB (EBD + area: 17±3%; P<0.05 vs I/R alone) and by 3 cycles of IPC consisting of 5 min ischemia and 10 min reperfusion (EBD + area: 11±4%; P<0.05 vs I/R alone). These data suggest that activation of NF‐κB plays a role in the excessive I/R‐induced injury in dystrophin‐deficient muscle and provide support for a protective effect of IPC to ameliorate this muscle damage. Supported by NIH AR051034.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here